NCT04419610View on ClinicalTrials.gov

RAS and Coagulopathy in COVID19

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

October 9, 2020

Primary Completion Date

May 12, 2021

Study Completion Date

May 12, 2021

Conditions
COVID
Interventions
BIOLOGICAL

TRV027

peptide for infusion

OTHER

sodium chloride 0.9%

placebo comparator for infusion

Trial Locations (1)

W12 0HS

Imperial College NHS Trust, London

All Listed Sponsors
lead

Imperial College London

OTHER

NCT04419610 - RAS and Coagulopathy in COVID19 | Biotech Hunter | Biotech Hunter